MHIA 6160 | Value & Quality in Healthcare | 1.50 | W27
The Five Pillars
Source: Marchildon, 2013
Source: Government of Canada, 2026
| Country | Hlth Exp. % of GDP |
Per Capita ($USD) |
Framework |
|---|---|---|---|
| United States | ~16.6 | ~12,555 | Private/Pluralistic |
| Canada | ~11.2 | ~6,319 | Mixed |
| OECD Average | ~9.2 | ~4,986 | Mixed |
System Lens:
Question
Key Empirical Insights:
Value v. Quality
The Pendulum
Centralized Governance
Decentralized Governance
Source: Armstrong, 1999
\[Value = \frac{Outcomes}{Costs}\]
| Governance Trade-Offs in Health Systems | ||
| Evaluating structural models through the Dual-Lens Strategy | ||
| Strategic Dimension | Centralized Model | Decentralized Model |
|---|---|---|
| Resource Allocation | Pooled risk, economies of scale | Fragmented risk pools |
| Local Responsiveness | Low (Rigid mandates) | High (Tailored to community needs) |
| Equity & Standardization | High (Standardized care pathways) | Variable ('Postal code lottery') |
| Administrative Overhead | Streamlined (Single-payer/manager) | Duplicative (Multiple IT/HR layers) |
Structural Tension
The System Lens (Public)
The Industry Lens (Private)
Value v. Quality
When a system is highly decentralized, the quality of care and access to innovation often depends on the wealth and tax base of the specific region a patient lives in, challenging the core premise of Canadian health equity.
Structural Tension
This dynamic creates a structural tension between macro-level equity goals (the public mandate) and micro-level operational efficiencies (private delivery).
Source: Machildon, 2012
Background:
Key Domains of Private Innovation:
Public Sector Advantage:
Purchasing Power: Centralized, public funding allows for economies of scale (e.g., pan-Canadian pharma negotiations).
Systemic Equity: Leverages broad risk pools to ensure standardized care pathways across diverse populations.
Private Sector Advantage:
Agility: Private delivery mechanisms can rapidly adapt operational workflows and adopt novel clinical protocols.
Capital Injection: Private entities can fund specialized facility-level infrastructure that public budgets cannot immediately support.
The Evaluation Imperative
| Country | Financing | Delivery | Implication |
|---|---|---|---|
| United Kingdom | Public | Public | Pro: Control & Integrated Con: Efficiency |
| United States | Private | Private | Pro: Innovation Con: Barriers |
| Canada | Public | Private | Striving for Equity & Agility |
Identifying Systemic Barriers: Requires synthesizing the relationship between potential access and realized utilization across both sectors.
Moving Past Ideological Debates: Requires evidence-based integration is required to successfully implement large-scale interventions.
The Leadership Challenge: How can public regulators effectively incentivize private innovation without widening health disparities?
The Standard Equation
\[Value = \frac{Outcomes}{Costs}\]
Source: Armstrong, 1999
Health Outcomes:
Outcome Tiers:
Costing Methodologies
\[\text{PPPY} = \text{Per Patient Per Year}\]
Hover over the facilities below to evaluate specific PPPY costs and outcome scores.
Primary Driver of Inefficiency:
Volume-Based (Fee-for-Service)
Value-Based Care
The Data & Analytics Connection:
R-Laboratory sessions, we will transition from defining value conceptually to measuring it quantitatively.Following our Week 1 R-Laboratory, we will dedicate the last 10 minutes for student participation in a Week 1 Evaluation.
Objective:
Following the Week 1 Student Evaluation, we will dedicate the last 30 min of the class for the Capstone Taskforce formation.
Capstone Task Force
Email Instructions
Software Prerequisites
OS.RStudio and ensure the R version prints in the console.Local File Hygiene
Build an R Project (.Rproj) to securely anchor your working directories.
Schulich School of Business, York University | Copyright © 2027 Cameron B. Chiarot | MHIA 6160